SCHEMBL28635966

SCHEMBL28635966

O[C@@H]1C[C@H](O)N1Cc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.55
CHRM4 P08173 1/20 0.55
CHRM5 P08912 1/20 0.55
FUCA1 P04066 2/20 0.50
MAPT P10636 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
SIGMAR1 Q99720 1/20 0.46
ALDH1A1 P00352 2/20 0.44
CYP3A4 P08684 1/20 0.42
TSHR P16473 1/20 0.42
CYP2C19 P33261 1/20 0.42
GBA1 P04062 2/20 0.42
OPRK1 P41145 2/20 0.42
ABCB1 P08183 1/20 0.42
ACHE P22303 1/20 0.41
OPRM1 P35372 1/20 0.41
KCNH2 Q12809 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26695363 0.87 FUCA1 (0.50) CHRM2CHRM4CHRM5FUCA1MAPT
SCHEMBL27969697 0.81 MAPT (0.51) CHRM2CHRM4CHRM5FUCA1MAPT
SCHEMBL28868216 0.79 CHRM2 (0.44) CHRM2CHRM4CHRM5FUCA1MAPT
SCHEMBL12830800 0.77 CHRM2 (0.59) CHRM2CHRM4CHRM5FUCA1MAPT
SCHEMBL16766562 0.76 CHRM2 (0.62) CHRM2CHRM4CHRM5MAPTMEN1
SCHEMBL16766586 0.76 CHRM2 (0.62) CHRM2CHRM4CHRM5MAPTMEN1
SCHEMBL694189 0.76 CHRM2 (0.62) CHRM2CHRM4CHRM5MAPTMEN1
SCHEMBL9167840 0.76 CHRM2 (0.62) CHRM2CHRM4CHRM5FUCA1MAPT
SCHEMBL693619 0.76 CHRM2 (0.53) CHRM2CHRM4CHRM5FUCA1MAPT
SCHEMBL13993541 0.76 CHRM2 (0.62) CHRM2CHRM4CHRM5MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113603683-A Substituted phenyl oxazolidinones for antimicrobial therapy 结核病药物开发全球联盟公司 2021-11-05 CN disclosed
CN-108348507-B Substituted phenyl oxazolidinones for antimicrobial therapy 结核病药物开发全球联盟公司 2021-10-08 CN disclosed